Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2026-05-24 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于公司董事、总经理增持股份暨持股5%以上股东梁武之一致行动人转让股份的预披露公告
Director's Dealing Classification · 92% confidence The document is a formal pre-disclosure announcement of planned share transactions by a company director and general manager (Xu Lei) and a concerted actor of a >5% shareholder (Sheng Lina). It details insider trading plans (bulk share purchases and transfers), insider identity, percentages, timeframes, and legal compliance. This fits the definition of Director’s Dealing (insider share transactions by directors/executives).
2026-05-24 Chinese
关于控股股东部分股份质押及解除质押的公告
Regulatory Filings Classification · 83% confidence The document is an announcement by the company concerning the pledge and release of share collateral by its controlling shareholder. It details the number of shares pledged, released, and outstanding, along with dates and counterparties. This is neither a financial report, dividend notice, securities issuance, nor an earnings release; it’s a regulatory disclosure specific to share pledges by a major shareholder. It does not report changes in ownership percentages but rather the status of pledged shares. It therefore does not match categories like MRQ, DIRS, POS, or CAP. As a miscellaneous regulatory filing that does not fit another category, it is best classified under Regulatory Filings (RNS).
2026-05-15 Chinese
关于与专业投资机构共同投资设立并购产业基金备案完成的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the filing (备案) of a joint investment in a merger and acquisition (M&A) industry fund with professional investment institutions. It details the company's board approval, the fund's establishment, and the official registration with the China Securities Investment Fund Association. The document is short (944 characters) and primarily serves as a progress update on a capital investment and fund formation, not a full financial report or detailed investor presentation. It does not contain financial statements or detailed financial data. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through the establishment of an investment fund. It is not a regulatory filing or report publication announcement because it provides substantive update information rather than just a notice of report availability.
2026-05-07 Chinese
2025年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2025 annual dividend distribution (权益分派实施公告) by 瑞普生物股份有限公司. It details the dividend amount per share, the total cash dividend, the record date, the ex-dividend date, and the method of dividend distribution. It also references the approval of the dividend plan at the 2025 annual shareholders meeting. The document is relatively short (2537 characters) and focuses on the dividend distribution details rather than presenting a full financial report or annual report. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders. Therefore, the correct classification is DIV with high confidence.
2026-05-07 Chinese
关于召开2025年年度股东会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2025 Annual General Meeting (AGM) of 瑞普生物股份有限公司, including the meeting date, voting procedures, agenda items, and instructions for shareholders. It does not contain financial statements or results but rather the announcement and procedural information for the AGM. The document length is about 4898 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-03-30 Chinese
中国银河证券股份有限公司关于瑞普生物股份有限公司2025年度募集资金存放、管理与使用情况专项报告的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from China Galaxy Securities Co., Ltd. regarding the 2025 annual special report on the deposit, management, and use of raised funds by Ruipu Bio Co., Ltd. It includes extensive financial data on the amount of funds raised, their usage, balances, changes in investment projects, and compliance with regulatory requirements. The document references regulatory approvals, specific dates in 2025, and detailed tables of fund usage and project progress. It is a specialized report focused on the management and use of capital raised through stock issuance, not a general annual report or earnings release. The document is lengthy (over 11,000 characters) and contains substantive financial and operational data related to capital raised and its deployment. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is CAP.
2026-03-30 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.